Use Options For a Chance To Buy RGLS at a 35% Discount

Looking back to 76 days ago, Regulus Therapeutics Inc (RGLS) priced a 5,294,118 share secondary stock offering at $17.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 10.8% above the offering price..